Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberWO2005097208 A3
Publication typeApplication
Application numberPCT/US2005/010112
Publication date26 Jan 2006
Filing date25 Mar 2005
Priority date26 Mar 2004
Also published asWO2005097208A2
Publication numberPCT/2005/10112, PCT/US/2005/010112, PCT/US/2005/10112, PCT/US/5/010112, PCT/US/5/10112, PCT/US2005/010112, PCT/US2005/10112, PCT/US2005010112, PCT/US200510112, PCT/US5/010112, PCT/US5/10112, PCT/US5010112, PCT/US510112, WO 2005/097208 A3, WO 2005097208 A3, WO 2005097208A3, WO-A3-2005097208, WO2005/097208A3, WO2005097208 A3, WO2005097208A3
InventorsChristopher David Batich, Edward Allan Ross
ApplicantChristopher David Batich, Edward Allan Ross, Univ Florida
Export CitationBiBTeX, EndNote, RefMan
External Links: Patentscope, Espacenet
Tissue oxygenation measurements
WO 2005097208 A3
Abstract
An effective contrast agent for use in MRI-based methods for directly determining tissue oxygenation in a subject using MRI equipment as well as methods for assessing tissue oxygenation were discovered. Methods employ a blood substitute bound to a water soluble polymer as an MRI contrast agent. In the experiments described herein, polyethylene glycol (PEG) derivatives of bovine hemoglobin (pegylated Hb or PEG-Hb) were used as the contrast agent.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US5498421 *22 Feb 199412 Mar 1996Vivorx Pharmaceuticals, Inc.Composition useful for in vivo delivery of biologics and methods employing same
Classifications
International ClassificationA61K49/00, A61K49/14
Cooperative ClassificationA61K49/126, A61K49/14
European ClassificationA61K49/12P, A61K49/14
Legal Events
DateCodeEventDescription
20 Oct 2005AKDesignated states
Kind code of ref document: A2
Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW
20 Oct 2005ALDesignated countries for regional patents
Kind code of ref document: A2
Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
14 Dec 2005121Ep: the epo has been informed by wipo that ep was designated in this application
27 Sep 2006NENPNon-entry into the national phase in:
Ref country code: DE
27 Sep 2006WWWWipo information: withdrawn in national office
Country of ref document: DE
20 Jun 2007122Ep: pct app. not ent. europ. phase